Earle Grueskin, a 77-year-old retired Gateway executive who lives in Carlsbad, is another patient who is benefiting from CyberKnife treatment.

Two years ago, he was diagnosed with prostate cancer, spotted when he had his annual PSA.  Like many prostate cancer patients, he had several options — almost too many, according to a recent report on MSNBC, which highlighted the confusion of multiple options for prostate cancer patients.

Having already gone through a stomach resection and brain surgery in his life, Earle was ready to investigate when he heard about an alternative to traditional prostate surgery: CyberKnife.

He did his homework, met with one of the physicians to ask questions and made his decision to go with CyberKnife because, as he said, "the science made sense to me."  As the third patient of the San Diego CyberKnife Center, he is a poster child for its success:   18 months after treatment his PSA levels have fallen to near zero, his minimal side effects have resolved and there is no sign of the cancer.